Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

NCT06051123

Conditions
ALS (Amyotrophic Lateral Sclerosis), ALSFTD, Amyotrophic Lateral Sclerosis, +12 more
Locations
  • Stan Cassidy Centre for Rehabilitation Fredericton, New Brunswick, Canada
  • Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada
  • University of Saskatchewan, Clinical Trials Support Unit Saskatoon, Saskatchewan, Canada
View Trial Details
Recruiting

Neurologic Stem Cell Treatment Study

NCT02795052

Conditions
ALS, Alzheimer Disease, Amyotrophic Lateral Sclerosis, +94 more
Locations
  • MD Stem Cells Westport, Connecticut, United States
  • MD Stem Cells Coral Springs, Florida, United States
  • The Saudi-German Hospital Dubai, United Arab Emirates
View Trial Details
Recruiting

A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)

NCT07071935

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +20 more
Locations
  • Penn State Hershey ALS Clinic Hershey, Pennsylvania, United States
  • Penn Comprehensive ALS Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States
  • Thomas Jefferson University Weinberg ALS Center Philadelphi, Pennsylvania, United States
View Trial Details
Recruiting

Tofersen in Non-SOD1 ALS

NCT07294144

Conditions
ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University ALS Center St Louis, Missouri, United States
View Trial Details
Recruiting

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

NCT07287397

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • St Joseph's Hospital and medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego Medical Center San Diego, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami School of Science Miami, Florida, United States
View Trial Details
Recruiting

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT07660614

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University Hospital Schleswig-Holstein, Campus Lübeck Lübeck, Germany
  • Istituto Neurologico "Carlo Besta" Milan, Italy
  • AOU Città della Salute e della Scienza di Torino Torino, Italy
  • Universitair Medisch Centrum Utrecht Utrecht, Netherlands
View Trial Details
Recruiting

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

NCT07369076

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Neuroscience Research Australia Randwick, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
  • Flinders Medical Centre Bedford Park, South Australia, Australia
View Trial Details

Related conditions